United States
Germany
Japan
United Kingdom
China
VIP (NM_003381) Human Tagged ORF Clone Lentiviral Particle
CAT＃: RC203126L3V
- LentiORF®
-
Lenti ORF particles, VIP (Myc-DDK tagged) - Human vasoactive intestinal peptide (VIP), transcript variant 1, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 7,410.00
Product images
CNY 2,950.00
CNY 1,999.00
CNY 2,700.00
Specifications
| Product Data | |
| Product Name | VIP (NM_003381) Human Tagged ORF Clone Lentiviral Particle |
| Synonyms | PHM27 |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| ACCN | NM_003381 |
| ORF Size | 507 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(RC203126).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_003381.2 |
| RefSeq Size | 1601 bp |
| RefSeq ORF | 513 bp |
| Locus ID | 7432 |
| Domains | GLUCA |
| Protein Families | Druggable Genome, Secreted Protein, Transmembrane |
| MW | 19.1 kDa |
| Gene Summary | The protein encoded by this gene belongs to the glucagon family. It stimulates myocardial contractility, causes vasodilation, increases glycogenolysis, lowers arterial blood pressure and relaxes the smooth muscle of trachea, stomach and gall bladder. The protein also acts as an antimicrobial peptide with antibacterial and antifungal activity. Alternative splicing occurs at this locus and two transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Nov 2014] |
Documents
| Product Manuals |
| FAQs |
| SDS |
